Finally, combining EVT0185 with anti-PDL1 and VEGFR antibodies in the WD-CCl4 model markedly reduced tumour burden and the proportion of animals with more than 25 tumours, overcoming the limited efficacy of immunotherapy alone (Fig. 3k–m and Extended Data Fig. 6j). This evidence concerns the gene CD274 and neoplasm.